Satellite communications specialist Inmarsat (LON:ISAT) plunged 9.21% to 352.80p after the company lost its 20-year monopoly on international maritime distress signals. US rival Iridium Communications has been certified by the UN to also provide the service, in theory. Get the latest from Master Investor directly in your inbox – Sign-up HERE for FREE Iridium’s ability…
Meat products specialist Cranswick (LON:CWK) has reported that revenues for the year ended 31st March were up by 17.6% at £1,464.5 million, helped by a 30.2% surge in export sales. Statutory pre-tax profits also rose by 13.5% to £88.0 million. Get the latest from Master Investor directly in your inbox – Sign-up HERE for FREE…
Halfords (LON:HFD) saw its pre-tax profits drop by 6% to £67.1 million over the year ended 30th March, as profit margins on its retail sales fell by 123 basis points. Total revenues were up by 3.7% at £1,135.1 million, but the bulk of this growth was in the lower margin retail division while autocentre sales…
Augmentum Fintech (LON:AUGM) is a new London-listed investment company that was created to profit from opportunities in the UK and European Fintech sector. It will concentrate on businesses with innovative technologies that have the power to change the way we conduct our financial affairs and will distribute 50% of the realised gains made each year. AUGM…
Shares in commercial biotech company Allergy Therapeutics (AGY) had shot up by 7.76% to 26.40p at 1320 BST after the company announced positive top line results from phase II trials for a treatment for glass allergies.
I was a bit surprised by a story in yesterday’s Sunday Telegraph to the effect that the total assets falling to be distributed by the administrators of Beaufort Securities was of the order of £500 million to £850 million but that the fee charged by PwC for this would be of the order of £100…
Italian gaming regulators have approved FTSE 250 gaming technology outfit Playtech’s (PTEC) €846 million acquisition of Snaitech.
Shares in drug maker AstraZeneca (AZN) rose had risen by 2.52% to 5,373p at 1100 BST after the US Food and Drug Administration approved Lokelma, which is designed to treat high blood potassium levels.
Far-sighted investors are assessing how they can position themselves to capitalise on any opening-up of the North Korean economy. I’ve stumbled across this Main Market listed company that appears to be the closest thing to a UK-listed play on this opportunity… Donald Trump is scheduled to meet Kim Jong Un in a historic summit in…
FTSE 100 miner Glencore (GLEN) has seen its shares tumble 4.56% to 380.60p this afternoon on the back of news that it will be investigated by the Serious Fraud Office.
